Graves' disease and hyperthyroidism trials in Spain
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- Where
- Alcalá de Henares, Córdoba
- Age
- 18 years to 75 years
- People
- 60 worldwide
- Run by
- Biogen
See details and how to joinNCT07722546 · EU 2026-526482-19-00 - Phase 3Taking peopleA Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
- Where
- Alzira, Barcelona, Burjassot, Girona, Málaga, Móstoles, Santander, Sevilla
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- argenx
See details and how to joinNCT07596849 · EU 2025-523333-26-00 - Phase 2Taking peopleA Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Where
- Madrid
- Age
- 18 years to 75 years
- People
- 210 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07018323 · EU 2025-521920-31-00 - Phase 1Taking peopleNEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
- Where
- A Coruna, Barcelona, Madrid, Málaga, Santander, Sevilla, Valencia
- Age
- 18 years to 65 years
- People
- 100 worldwide
- Run by
- Merida Biosciences
See details and how to joinNCT07305818 · EU 2025-523823-23-00 - Phase 2Taking peopleA Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
- Where
- Barcelona, Pamplona, Seville
- Age
- 18 years to 75 years
- People
- 30 worldwide
- Run by
- Sanofi
See details and how to joinNCT06984627 - Phase 2Taking peopleA Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Where
- Badalona, Barcelona, Córdoba, Granada, Madrid, Pamplona, Sevilla
- Age
- 18 years to 75 years
- People
- 240 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT06727604 · EU 2024-516020-33-00 - Phase 2Taking peopleA Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
- Where
- Badalona, Barcelona, Córdoba, Granada, Madrid, Pamplona, Sevilla
- Age
- 18 years and over
- People
- 128 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to join2025-524001-33-00 - Phase 2Taking peopleStudy to Assess K1-70 in Participants with Active Thyroid Eye Disease
- Where
- Barcelona, Cordoba, Granada, Madrid, Sevilla
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- Av7 Limited
See details and how to join2024-519292-26-00 - No phaseTaking peopleThyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis
- Where
- Granada, Marbella
- Age
- 18 years and over
- People
- 486 worldwide
- Run by
- Andrea Goldmann
See details and how to joinNCT06963203